A newly developed agonistic antibody reduced the amyloid pathology in mice with Alzheimer’s disease, signaling its promise as a potential treatment for the disease, according
Depression, anxiety, worry, perceived stress, and loneliness measured early in the pandemic, before infection with COVID-19, were associated with up to 45% increased risk of